JP Stock MarketDetailed Quotes

3543 Komeda Holdings

Watchlist

2836
-9-0.32%

20min DelayNot Open Dec 30 15:30 JST

131.20BMarket Cap21.81P/E (Static)

Komeda Holdings Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Aug 31, 2024

(Q1)May 31, 2024

(FY)Feb 29, 2024

(Q4)Feb 29, 2024

(Q3)Nov 30, 2023

(Q2)Aug 31, 2023

(Q1)May 31, 2023

(FY)Feb 28, 2023

(Q4)Feb 28, 2023

(Q3)Nov 30, 2022

Total revenue

10.88%12.01B

5.70%11.05B

14.27%43.24B

8.06%11.12B

14.81%10.84B

18.33%10.83B

16.69%10.45B

13.56%37.84B

18.72%10.29B

14.16%9.44B

Cost of revenue

9.35%7.84B

6.78%7.31B

15.24%28.63B

9.41%7.45B

15.47%7.16B

18.84%7.17B

18.10%6.84B

16.79%24.84B

21.92%6.81B

17.72%6.2B

Gross profit

13.86%4.16B

3.66%3.74B

12.42%14.61B

5.41%3.67B

13.54%3.67B

17.36%3.66B

14.10%3.61B

7.87%12.99B

12.92%3.48B

7.91%3.23B

Operating expense

14.33%1.82B

20.46%1.63B

18.52%5.89B

23.85%1.57B

16.72%1.38B

30.30%1.59B

3.91%1.35B

4.83%4.97B

-21.95%1.27B

24.13%1.18B

Selling and administrative expenses

15.36%1.86B

15.39%1.66B

12.82%6.01B

11.10%1.59B

11.65%1.37B

27.47%1.62B

2.35%1.44B

8.49%5.33B

3.54%1.43B

8.97%1.23B

-General and administrative expense

15.36%1.86B

15.39%1.66B

12.82%6.01B

11.10%1.59B

11.65%1.37B

27.47%1.62B

2.35%1.44B

8.49%5.33B

3.54%1.43B

8.97%1.23B

Other operating expenses

100.00%6M

----

264.10%142M

431.58%101M

1,300.00%28M

-82.35%3M

900.00%10M

-87.70%39M

-93.93%19M

--2M

Total other operating income

85.19%50M

-71.74%26M

-33.50%266M

-32.97%124M

-54.90%23M

-57.14%27M

-8.91%92M

-18.37%400M

150.00%185M

-71.19%51M

Operating profit

13.50%2.35B

-6.43%2.11B

8.64%8.72B

-5.15%2.1B

11.72%2.3B

9.02%2.07B

21.23%2.26B

9.84%8.02B

51.71%2.21B

0.39%2.06B

Net non-operating interest income (expenses)

-166.67%-64M

80.00%-2M

-39.13%-32M

74.47%-12M

151.85%14M

-2,500.00%-24M

-120.00%-10M

81.75%-23M

43.37%-47M

-800.00%-27M

Non-operating interest income

-30.00%7M

5.88%18M

-7.69%48M

125.93%7M

--14M

-52.38%10M

-74.24%17M

10.64%52M

-437.50%-27M

----

Non-operating interest expense

108.82%71M

-25.93%20M

6.67%80M

-5.00%19M

--0

70.00%34M

68.75%27M

-56.65%75M

-78.02%20M

17.39%27M

Net investment income

Gain(Loss) on financial instruments designated as cash flow hedges

Gain(Loss) on derecognition of available-for-sale financial assets

Income from associates and other participating interests

Special income (charges)

Other non-operating income (expenses)

Income before tax

11.70%2.28B

-6.10%2.11B

8.55%8.69B

-3.65%2.09B

13.90%2.31B

7.70%2.04B

17.53%2.25B

11.45%8B

57.45%2.17B

-0.78%2.03B

Income tax

11.35%726M

-6.15%672M

6.19%2.71B

-12.17%606M

13.73%737M

7.77%652M

17.38%716M

14.33%2.55B

83.02%690M

-0.92%648M

Net income

11.87%1.56B

-6.08%1.44B

9.65%5.97B

0.34%1.48B

13.98%1.57B

7.67%1.39B

17.60%1.53B

10.15%5.45B

47.80%1.48B

-0.72%1.38B

Net income continuous operations

11.87%1.56B

-6.08%1.44B

9.65%5.97B

0.34%1.48B

13.98%1.57B

7.67%1.39B

17.60%1.53B

10.15%5.45B

47.80%1.48B

-0.72%1.38B

Noncontrolling interests

-91.67%2M

-60.00%2M

100.00%24M

-42.86%4M

225.00%13M

Net income attributable to the company

11.87%1.56B

-5.96%1.44B

10.10%5.97B

0.61%1.48B

15.06%1.57B

7.84%1.39B

17.90%1.53B

9.93%5.42B

48.44%1.47B

-1.37%1.37B

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

11.87%1.56B

-5.96%1.44B

10.10%5.97B

0.61%1.48B

15.06%1.57B

7.84%1.39B

17.90%1.53B

9.93%5.42B

48.44%1.47B

-1.37%1.37B

Gross dividend payment

Basic earnings per share

12.66%34.18

-5.16%31.43

10.65%130.12

1.22%32.29

15.86%34.34

8.55%30.34

17.89%33.14

9.89%117.6

48.51%31.9

-1.46%29.64

Diluted earnings per share

12.70%34.17

-5.16%31.41

10.78%130.03

1.35%32.27

15.99%34.32

8.67%30.32

18.07%33.12

9.94%117.38

48.51%31.84

-1.40%29.59

Dividend per share

3.85%27

1.92%53

3.85%27

0.00%26

1.96%52

0.00%26

Currency Unit

JPY

Accounting Standards

NonUS-GAAP

	(Q2)Aug 31, 2024	(Q1)May 31, 2024	(FY)Feb 29, 2024	(Q4)Feb 29, 2024	(Q3)Nov 30, 2023	(Q2)Aug 31, 2023	(Q1)May 31, 2023	(FY)Feb 28, 2023	(Q4)Feb 28, 2023	(Q3)Nov 30, 2022
Total revenue	10.88%12.01B	5.70%11.05B	14.27%43.24B	8.06%11.12B	14.81%10.84B	18.33%10.83B	16.69%10.45B	13.56%37.84B	18.72%10.29B	14.16%9.44B
Cost of revenue	9.35%7.84B	6.78%7.31B	15.24%28.63B	9.41%7.45B	15.47%7.16B	18.84%7.17B	18.10%6.84B	16.79%24.84B	21.92%6.81B	17.72%6.2B
Gross profit	13.86%4.16B	3.66%3.74B	12.42%14.61B	5.41%3.67B	13.54%3.67B	17.36%3.66B	14.10%3.61B	7.87%12.99B	12.92%3.48B	7.91%3.23B
Operating expense	14.33%1.82B	20.46%1.63B	18.52%5.89B	23.85%1.57B	16.72%1.38B	30.30%1.59B	3.91%1.35B	4.83%4.97B	-21.95%1.27B	24.13%1.18B
Selling and administrative expenses	15.36%1.86B	15.39%1.66B	12.82%6.01B	11.10%1.59B	11.65%1.37B	27.47%1.62B	2.35%1.44B	8.49%5.33B	3.54%1.43B	8.97%1.23B
-General and administrative expense	15.36%1.86B	15.39%1.66B	12.82%6.01B	11.10%1.59B	11.65%1.37B	27.47%1.62B	2.35%1.44B	8.49%5.33B	3.54%1.43B	8.97%1.23B
Other operating expenses	100.00%6M	----	264.10%142M	431.58%101M	1,300.00%28M	-82.35%3M	900.00%10M	-87.70%39M	-93.93%19M	--2M
Total other operating income	85.19%50M	-71.74%26M	-33.50%266M	-32.97%124M	-54.90%23M	-57.14%27M	-8.91%92M	-18.37%400M	150.00%185M	-71.19%51M
Operating profit	13.50%2.35B	-6.43%2.11B	8.64%8.72B	-5.15%2.1B	11.72%2.3B	9.02%2.07B	21.23%2.26B	9.84%8.02B	51.71%2.21B	0.39%2.06B
Net non-operating interest income (expenses)	-166.67%-64M	80.00%-2M	-39.13%-32M	74.47%-12M	151.85%14M	-2,500.00%-24M	-120.00%-10M	81.75%-23M	43.37%-47M	-800.00%-27M
Non-operating interest income	-30.00%7M	5.88%18M	-7.69%48M	125.93%7M	--14M	-52.38%10M	-74.24%17M	10.64%52M	-437.50%-27M	----
Non-operating interest expense	108.82%71M	-25.93%20M	6.67%80M	-5.00%19M	--0	70.00%34M	68.75%27M	-56.65%75M	-78.02%20M	17.39%27M
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges)
Other non-operating income (expenses)
Income before tax	11.70%2.28B	-6.10%2.11B	8.55%8.69B	-3.65%2.09B	13.90%2.31B	7.70%2.04B	17.53%2.25B	11.45%8B	57.45%2.17B	-0.78%2.03B
Income tax	11.35%726M	-6.15%672M	6.19%2.71B	-12.17%606M	13.73%737M	7.77%652M	17.38%716M	14.33%2.55B	83.02%690M	-0.92%648M
Net income	11.87%1.56B	-6.08%1.44B	9.65%5.97B	0.34%1.48B	13.98%1.57B	7.67%1.39B	17.60%1.53B	10.15%5.45B	47.80%1.48B	-0.72%1.38B
Net income continuous operations	11.87%1.56B	-6.08%1.44B	9.65%5.97B	0.34%1.48B	13.98%1.57B	7.67%1.39B	17.60%1.53B	10.15%5.45B	47.80%1.48B	-0.72%1.38B
Noncontrolling interests	0	0	-91.67%2M	0	0	0	-60.00%2M	100.00%24M	-42.86%4M	225.00%13M
Net income attributable to the company	11.87%1.56B	-5.96%1.44B	10.10%5.97B	0.61%1.48B	15.06%1.57B	7.84%1.39B	17.90%1.53B	9.93%5.42B	48.44%1.47B	-1.37%1.37B
Preferred stock dividends
Other under preferred stock dividend	0	0	0	0	0	0	0	0	0	0
Net income attributable to common stockholders	11.87%1.56B	-5.96%1.44B	10.10%5.97B	0.61%1.48B	15.06%1.57B	7.84%1.39B	17.90%1.53B	9.93%5.42B	48.44%1.47B	-1.37%1.37B
Gross dividend payment
Basic earnings per share	12.66%34.18	-5.16%31.43	10.65%130.12	1.22%32.29	15.86%34.34	8.55%30.34	17.89%33.14	9.89%117.6	48.51%31.9	-1.46%29.64
Diluted earnings per share	12.70%34.17	-5.16%31.41	10.78%130.03	1.35%32.27	15.99%34.32	8.67%30.32	18.07%33.12	9.94%117.38	48.51%31.84	-1.40%29.59
Dividend per share	3.85%27	0	1.92%53	3.85%27	0	0.00%26	0	1.96%52	0.00%26	0
Currency Unit	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP

Symbol Price % Chg

D. Western Therapeutics Institute

4576

201 +23.31%

See the daily top gainer.